CATALOGO DEI PRODOTTI DELLA RICERCA

GATTI, Davide
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.917
EU - Europa 10.430
AS - Asia 7.959
SA - Sud America 1.176
AF - Africa 119
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 11
Totale 31.630
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.773
GB - Regno Unito 3.890
SG - Singapore 3.104
CN - Cina 2.937
IT - Italia 1.140
BR - Brasile 1.012
DE - Germania 970
HK - Hong Kong 907
RU - Federazione Russa 895
SE - Svezia 841
FR - Francia 819
IE - Irlanda 738
FI - Finlandia 596
KR - Corea 224
UA - Ucraina 205
IN - India 143
VN - Vietnam 136
TR - Turchia 129
JP - Giappone 119
CA - Canada 72
NL - Olanda 69
AR - Argentina 48
BE - Belgio 44
MX - Messico 43
ID - Indonesia 42
BD - Bangladesh 41
AT - Austria 34
PL - Polonia 34
IQ - Iraq 33
EC - Ecuador 31
ES - Italia 28
ZA - Sudafrica 28
TG - Togo 27
CO - Colombia 22
CL - Cile 21
IR - Iran 21
RO - Romania 21
UZ - Uzbekistan 21
VE - Venezuela 19
EG - Egitto 15
PK - Pakistan 15
CZ - Repubblica Ceca 13
AU - Australia 12
MA - Marocco 11
PT - Portogallo 11
SA - Arabia Saudita 10
CH - Svizzera 9
SK - Slovacchia (Repubblica Slovacca) 9
DZ - Algeria 8
A2 - ???statistics.table.value.countryCode.A2??? 7
KE - Kenya 7
PE - Perù 7
PY - Paraguay 7
AL - Albania 6
BG - Bulgaria 6
BO - Bolivia 6
GR - Grecia 6
HR - Croazia 6
IL - Israele 6
NP - Nepal 6
AZ - Azerbaigian 5
CR - Costa Rica 5
JO - Giordania 5
NZ - Nuova Zelanda 5
QA - Qatar 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
GE - Georgia 4
JM - Giamaica 4
KW - Kuwait 4
LB - Libano 4
LT - Lituania 4
LV - Lettonia 4
SN - Senegal 4
TH - Thailandia 4
AM - Armenia 3
BW - Botswana 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
EE - Estonia 3
HU - Ungheria 3
KG - Kirghizistan 3
MK - Macedonia 3
PH - Filippine 3
PS - Palestinian Territory 3
RS - Serbia 3
SI - Slovenia 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
CY - Cipro 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
IS - Islanda 2
LK - Sri Lanka 2
ME - Montenegro 2
MY - Malesia 2
NO - Norvegia 2
PA - Panama 2
Totale 31.588
Salva come PNG Salva come JPEG
Città #
Southend 3.616
Chandler 1.642
Jacksonville 1.488
Singapore 1.422
Dallas 1.354
Hong Kong 889
Woodbridge 787
Dublin 730
Ann Arbor 645
Ashburn 619
Houston 466
Beijing 430
Wilmington 311
Princeton 304
Lawrence 303
Jinan 254
New York 221
Nanjing 217
Shenyang 205
Los Angeles 196
Bologna 193
Redmond 190
Verona 184
Helsinki 150
Munich 140
Hebei 133
Buffalo 132
Sindelfingen 123
Tianjin 119
The Dalles 113
Tokyo 107
Milan 106
Columbus 95
Changsha 92
Haikou 85
Ningbo 85
Redondo Beach 84
Zhengzhou 84
Nanchang 81
Taizhou 72
Hangzhou 70
São Paulo 68
Boardman 67
Guangzhou 64
Jiaxing 64
San Francisco 61
Santa Clara 61
Taiyuan 61
Turku 57
Seattle 53
Redwood City 45
Washington 44
Hyderabad 43
Norwalk 43
Brussels 42
Falls Church 40
Ho Chi Minh City 39
Rome 38
Fairfield 37
Moscow 37
Fuzhou 33
Lanzhou 33
Rio de Janeiro 31
Detroit 30
Düsseldorf 30
Jakarta 29
Warsaw 29
Seoul 28
Chicago 27
Lomé 27
Belo Horizonte 26
Brasília 26
Brooklyn 26
Dearborn 26
Lancaster 26
Toronto 25
Council Bluffs 22
London 22
Atlanta 21
Boston 21
Phoenix 21
Vienna 21
Dongguan 20
Porto Alegre 20
Dong Ket 19
Hanoi 19
Mexico City 19
Orani 19
Tashkent 19
Frankfurt am Main 17
Nürnberg 17
Quito 16
Sanayi 16
Campinas 15
Meda 15
Shanghai 15
Auburn Hills 13
Guarulhos 13
Johannesburg 13
Venice 13
Totale 20.379
Salva come PNG Salva come JPEG
Nome #
Teriparatide and denosumab combination therapy and skeletal metabolism 267
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 200
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 187
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 186
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 184
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 179
Association of CTR and COLIA1 alleles with BMD values in peri and postmenopausal women 177
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 170
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 169
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 169
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 168
[Therapeutic strategies in osteoporosis: whom and when to treat] 161
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 157
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 153
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 149
Bone metabolism in patients with anorexia nervosa and amenorrhoea 148
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 147
Anti-CCP antibodies and bone 147
Type VI Osteogenesis imperfecta: effect of plasma transfusion on bone metabolism 145
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 145
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 143
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 141
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 141
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 141
[Risk factors for hip fracture in elderly persons]. 141
Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases 139
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 139
Rapporti tra sistema immune e metabolismo osseo 138
Prevalence and incidence of rheumatoid arthritis in Italy. 138
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 137
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 137
DXA bone mineral density in males: retrospective study in real life. 136
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 136
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 136
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 135
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 135
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 135
Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control study. 134
Association between bone mineral density and serum lipid in men 133
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 133
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 132
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 132
Guidelines for the diagnosis, prevention and management of osteoporosis 132
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 130
Coxibs: a significant therapeutic opportunity. 129
Bone involvement and osteoporosis in mastocytosis. 129
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 128
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 127
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 127
Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women 125
Osteoporosis treatment: why ibandronic acid? 125
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 125
[Antinflammatory therapy and cardiovascular risk: a consensus view]. 124
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 122
Safety issues and adverse reactions with osteoporosis management 121
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 121
Could γ\δ T-cells explain zoledronic acid adverse events? 121
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 121
Allergy and the bone: unexpected relationships 120
Prevalence of osteoporosis in patients affected by mastocytosis 120
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 120
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 120
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 119
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 119
Effects of two oral doses of alendronate in the treatment of Paget's disease of bone 117
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 117
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 116
Drug-induced osteonecrosis of the jaw: the state of the art 116
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 116
Association between bone mineral density and serum lipids in men 115
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 115
Bone turnover markers in patients with osteogenesis imperfecta. 115
Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study 115
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 115
Periostin: The bone and beyond 115
Bone turnover markers in patients with osteogenesis imperfecta 114
Intermittent etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH Agonist. 114
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 114
Sclerostin and DKK1 in primary hyperparathyroidism. 114
Vitamin D affects insulin sensitivity and β-cell function in obese non-diabetic youths 114
Effects of denosumab on peripheral lymphocyte subpopulations 113
Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis. 112
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 111
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 111
Artropatie degenerative 110
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 110
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 110
Duration of treatment for osteoporosis 110
Positive effects of cyclic administration of intravenous neridronate in growing patients with osteogenesis imperfecta 109
MEDAL con etoricoxib: l’inizio di una nuova era per il trattamento del dolore muscolo scheletrico 109
Peak bone mass and peak bone density. 109
The radiological assessment of vertebral osteoporosis 108
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. 108
[Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures]. 108
Focal bone involvement in inflammatory arthritis: the role of IL17 108
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 108
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 107
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 107
Intravenous intermittent neridronate in the treatment of postmenopausal osteoporosis. 106
GH in combination with bisphosphonate treatment in osteogenesis imperfecta 106
Totale 13.167
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.960
article - articoli 121.359
book - libri 0
conference - conferenze 513
curatela - curatele 0
other - altro 131
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.957
Totale 249.920
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.739 0 0 0 328 324 267 61 155 230 18 259 97
2021/20222.363 195 608 27 111 119 113 37 130 169 65 196 593
2022/20234.908 372 430 477 889 434 1.180 55 262 535 46 167 61
2023/20242.537 106 207 229 306 306 415 111 184 43 100 364 166
2024/20256.683 358 448 296 1.026 347 198 306 298 999 579 533 1.295
2025/20264.044 1.371 996 1.473 204 0 0 0 0 0 0 0 0
Totale 32.170